NCT01619865
- Conditions
- Adenocarcinoma, Carcinoid Tumor, Carcinoid Tumors, +14 more
- Locations
-
- University of Iowa Health Care Iowa City, Iowa, United States
Clinical trial condition
Neuroendocrine Tumors
Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.
387 public trials
106 recruiting studies
Neuroendocrine Tumors trial results
NCT01789281
- Conditions
- Adenocarcinoma, Carcinoid Tumor, Carcinoma, +7 more
- Locations
-
- Hematology Oncology Services of Arkansas SC Little Rock, Arkansas, United States
- Rocky Mountain Cancer Centers SC Greenwood Village, Colorado, United States
- Stamford Hospital Stamford, Connecticut, United States
- H Lee Moffitt Cancer Center and Research Institute SC-2 Tampa, Florida, United States
NCT02810600
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
- Locations
-
- Centre hospitalier universitaire de Sherbrooke Sherbrooke, Quebec, Canada
NCT02973204
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +17 more
- Locations
-
- Department of Hepatology and Gastroenterology Aarhus, Aarhus C, Denmark
NCT02939651
- Conditions
- Neoplasm Metastasis, Neoplasms, Neoplasms by Histologic Type, +7 more
- Locations
-
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
- MD Anderson Cancer Center Houston, Texas, United States
NCT04780737
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gut Tumor, +8 more
- Locations
-
Not specified
NCT04753229
- Conditions
- Adenoma, Adenoma, Islet Cell, Digestive System Diseases, +13 more
- Locations
-
Not specified
NCT04207762
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
- Locations
-
- BC Cancer Vancouver, British Columbia, Canada
NCT02441062
- Conditions
- Adenocarcinoma, Carcinoid Tumor, Carcinoid Tumors, +14 more
- Locations
-
- University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
Completed
Dose Escalation Study of Pasireotide (SOM230) in Patients With Advanced Neuroendocrine Tumors (NETs)
NCT01364415
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
- Locations
-
- Cedars Sinai Medical Center Cedars Sinai 4 Los Angeles, California, United States
- H. Lee Moffitt Cancer Center & Research Institute SC-1 Tampa, Florida, United States
- Dana Farber Cancer Institute SC-6 Boston, Massachusetts, United States
- University of Texas/MD Anderson Cancer Center UT MD Anderson Cancer Ctr Houston, Texas, United States